https://www.selleckchem.com/pr....oducts/VX-680(MK-045
25; 95% CI, 0.19-0.33 [P less then 0.001] and 1-year HR, 0.40; 95% CI, 0.33-0.48 [P less then 0.001] or no preoperative exposure/no current exposure (30-day HR, 0.44; 95% CI, 0.32-0.60 [P less then 0.001] and 1-year HR, 0.72; 95% CI, 0.62-0.84 [P less then 0.001] groups. The no preoperative exposure/current exposure group had significantly lower 30-day (HR, 0.31; 95% CI, 0.14-0.71 [P=0.006]) and 1-year (HR, 0.64; 95% CI, 0.53-0.77 [P less then 0.001]) mortality than the no preoperative exposure/no current exposure group. Conclus